Clinical trial

Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients

NCT00309478

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date1990-12-01

PhasePHASE3

Study timeline

Study start (actual)1990-12-01Date precision: month

Registry last updated2023-06-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Early-stage Breast Cancerunresolved

Interventions

CyclophosphamideDRUG · verified · RxNorm: cyclophosphamide

MethotrexateDRUG · verified · RxNorm: methotrexate

Fluorouracil implantDRUG

GoserelinDRUG · verified · RxNorm: goserelin

TamoxifenDRUG · verified · RxNorm: tamoxifen

Sponsors & collaborators

Austrian Breast & Colorectal Cancer Study Grouplead sponsor

AstraZenecacollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00309478 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.